Axalta Coating Systems vs Solstice Advanced Materials
AXTA and SOLS side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXTA and SOLS compare
Solstice Advanced Materials is the larger company, worth 1.3 times as much as Axalta Coating Systems ($10.5B against $7.8B).
On earnings, Axalta Coating Systems is cheaper: it trades at 23.6× trailing earnings, against 32.4× for Solstice Advanced Materials.
Solstice Advanced Materials grew revenue faster over the last twelve months (9.4% versus 0.14% for Axalta Coating Systems).
Solstice Advanced Materials keeps more of each dollar of sales as profit, with a net margin of 7.8% compared with 6.5% at Axalta Coating Systems.
Solstice Advanced Materials pays a dividend yielding 0.34%; Axalta Coating Systems does not pay one.
Axalta Coating Systems scores higher on the StockData Score (12 against 7 for Solstice Advanced Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXTA | SOLS |
|---|---|---|
| Size and price | ||
| Market cap | $7.8B | $10.5B |
| Share price | $36.56 | $66.12 |
| Change, 1 year | 24.7% | 40.9% |
| Change, 5 years | 9.8% | – |
| Beta (5Y) | 1.08 | – |
| Employees | 12K | 4,100 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 4 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 (better) | 2 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 23.6× (better) | 32.4× |
| P/S | 1.5× (better) | 2.5× |
| P/B | 3.0× (better) | 6.7× |
| EV/EBITDA | 10.8× | – |
| P/FCF | 15.7× (better) | 23.5× |
| PEG | 0.89 | – |
| FCF yield | 6.4% (better) | 4.2% |
| Fair value | $40.23 | $45.19 |
| Margin of safety | 9.1% (better) | −46.3% |
| Growth | ||
| Revenue growth (TTM) | 0.14% | 9.4% (better) |
| Revenue growth, 5Y average | 6.5% | – |
| Net income growth (TTM) | −26.6% | −1.2% (better) |
| EPS growth (TTM) | −25.8% | – |
| EPS growth, 5Y average | 27.3% | – |
| Profitability | ||
| Gross margin | 33.6% (better) | 30.9% |
| Operating margin | 12.4% | – |
| Net margin | 6.5% | 7.8% (better) |
| FCF margin | 9.6% | 10.7% (better) |
| Return on equity | 13.6% (better) | 13.6% |
| Return on invested capital | 8.8% | – |
| Financial health | ||
| Debt / equity | 1.14 (better) | 1.26 |
| Net debt / EBITDA | 2.47 | – |
| Interest coverage | 4.2× | – |
| Current ratio | 1.53 (better) | 1.38 |
| Altman Z-score | 2.45 (better) | 2.30 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.34% |
| Payout ratio | – | 473% |
| Shareholder yield | 0.00% | 0.34% (better) |
| Ownership | ||
| Held by institutions | 106% | 84.4% |
| Held by insiders | 0.49% | 0.04% |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 4.2% | 2.9% |
Go deeper
- AXTA stock overview
- AXTA income statement
- AXTA valuation and score
- SOLS stock overview
- SOLS income statement
- SOLS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.